Sotalol Hydrochloride
Product Images NDC 10135-717
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 10135-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Study 1—time To First Ecg-documented Recurrence Of Symptomatic Afib/afl Since Randomization (Sotalol Hydrochloride Tablets Af 02)
Figure 2 Study 2 – Time To First Ecg-documented Recurrence Of Symptomatic Afib/afl/death Since Randomization (Sotalol Hydrochloride Tablets Af 03)
Formula (Sotalol Hydrochloride Tablets Af 04)
Graph (Sotalol Hydrochloride Tablets Af 05)
Ndc 10135-0715-01 100 Tabletssotalol Hydrochloride Tablets, Usp (af)80 mgrx Only (Sotalol Hydrochloride Tablets Af 06)
Ndc 10135-0716-01100 Tabletssotalol Hydrochloride Tablets, Usp (af)120 mgrx Only (Sotalol Hydrochloride Tablets Af 07)
Ndc 10135-0717-01100 Tabletssotalol Hydrochloride Tablets, Usp (af)160 mg Rx Only (Sotalol Hydrochloride Tablets Af 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.